About Cholesterol — Metabolic Health.
LDL, HDL, triglycerides, and lipid profile management.
Audited published research per compound. Drill into a pair for the breakdown.
Bar length counts published studies — green marks studies reporting at least one benefit, slate the other studies (no benefit, unclear or harm); labels read benefit studies / all studies.
◆ marks each compound's research score (0-100): how consistently published studies reported a benefit, weighted by study design. It summarises the research, not how well a compound will work for you.
Compounds with published trial evidence for this condition, ranked by strength of evidence. Each result is put in plain terms and comes from the study itself — open “Exact figures” for the published statistics, or follow the study link to read the paper.
| Compound | Evidence strength | What studies found |
|---|---|---|
| BerberineResearch score 62/100 · Moderate | 1 systematic review/meta-analysis + 2 randomised trials — 3 studies | 19/22 outcomes showed benefit
|
We publish community results for cholesterol only once at least 10 people have reported on the same compound — so no individual report is ever shown. Until then, here is the research side on its own.
Used something for cholesterol? Sharing how it went for you helps the next person — it is only ever published as part of a group of 10 or more.
Add your outcomeOpen the original papers, check their methods, and discuss what is relevant with a qualified professional.
Every study behind the numbers above is linked next to its result.
Ordered by strength of evidence, then result direction.
01Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-AnalysisMiao R, et al. · Phytotherapy research : PTR · 2025Systematic Review · matched via Cholesterol · PubMed record (CORPUS-A)
PMID 40439602 ↗02Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trialsLiu D, et al. · Frontiers in pharmacology · 2025Systematic Review · matched via Cholesterol · PubMed record (CORPUS-A)
PMID 40740996 ↗03The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic reviewNie Q, et al. · Journal of translational medicine · 2024Meta-Analysis · matched via Cholesterol · PubMed record (CORPUS-A)
PMID 38429794 ↗04A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adultsOsadnik T, et al. · Pharmacological research · 2022Network Meta-Analysis · matched via Cholesterol · PubMed record (CORPUS-A)
PMID 35988871 ↗05Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysisThese compounds appear in related research or traditional use. Their position is not a recommendation or ranking. Research scores summarise published studies only.
Network Meta-Analysis · matched via Cholesterol · PubMed record (CORPUS-A)
Outcome summaries extracted from the linked papers' curated records. Educational, not medical advice.
Ordered by strength of evidence, then result direction.
Figures are reported as published; study designs and populations vary. Works for Us does not interpret results or provide medical advice.